GlassScriptPhysician profile
Mitchell Paul Rosen
NPI 1730123662
$66,878.75
in general payments reported to CMS, 2019-2025
4 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.40 · 2021: $26.53 · 2022: $16K · 2024: $15K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Food and Beverage: $17.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,000.00 |
| Food and Beverage | $17.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vitrolife INC. | $51,046.93 | 2019-2025 | |
| Merck Kgaa | $12,040.00 | 2022 | |
| Coopersurgical, INC. | $3,774.16 | 2022 | |
| Novo Nordisk INC | $17.66 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.